indications

Nonclinical and Clinical Studies of the New Anti-Tuberculosis Drug «Perchlozone®»

Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(1):42-48

This article describes clinical development stages for the novel anti-TB drug «Perchlozone®», which has been approved in Russian Federation in 2012. Based on the phase I–III clinical studies results, efficacy and safety of the drug were assessed, and …

Midecamycin: Brief Clinico-pharmacological Review

Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(1):66-72

Macrolides are widely used antibiotics in a variety of infections, especially community-aquired. The clinical success of macrolides is due to their activity against classical causative agents, intracellular pathogens, and some protozoa. Of great …

Intravenous Immunoglobulins: Mechanisms of Action and Possible Clinical Applications

Clinical Microbiology and Antimicrobial Chemotherapy.2004; 6(3):273-281

Historically, intravenous immunoglobulins (ivIg) were initially used as replacement therapy in patients with antibody deficiency disorders.Later on ivIg were suggested to have advantages in treatment of patients with autoimmune and systemic …